The global infectious disease diagnostics market is expected to rise at a CAGR of 7.2 percent from USD 28.1 billion in 2021 to USD 39.8 billion in 2026. The global incidence of infectious diseases and the emergence of COVID-19, as well as rising awareness for early disease identification, a shift in focus from centralised laboratories to distributed POC testing, and technical improvements, are driving market expansion. Infectious disease prevalence in both established and developing nations will boost the infectious disease diagnostics market's growth. The rising number of prescriptions for infectious disease diagnostic tests is due to the diagnosis and management of such disorders. During the projection period, these factors, combined with the growing tendency toward preventative care, are projected to increase demand for infectious disease diagnostics.